Propofol and remifentanil pharmacodynamic interaction during orthopedic surgical procedures as measured by effects on bispectral index
- PMID: 11377158
- DOI: 10.1016/s0952-8180(01)00255-0
Propofol and remifentanil pharmacodynamic interaction during orthopedic surgical procedures as measured by effects on bispectral index
Abstract
Study objective: To identify and quantify the interaction between propofol and remifentanil during surgical procedures with a bispectral index (BIS) of 50 that was chosen as a continuous surrogate measure for "adequate depth" of anesthesia.
Design: Prospective, open-label study.
Setting: Department of orthopedics of a university hospital.
Patients: 20 patients undergoing orthopedic surgery.
Interventions: Anesthesia was induced and maintained with propofol and remifentanil, both administered by target-controlled infusion (TCI). Initial target concentrations of propofol (1.5-8 microg/mL) and remifentanil (2-15 ng/mL) were chosen and alternated in order to maintain the BIS between 45 and 55. If constant target concentrations had been maintained for 20 minutes and the BIS did not depart from the desired range, blood samples were taken to determine propofol concentrations, and the BIS value was recorded. Isobolographic interaction models were fitted to the infusion rates of remifentanil and propofol, predicted target concentrations of both drugs, and measured propofol concentrations versus predicted remifentanil concentrations.
Main results: The isobole for the interaction of propofol and remifentanil in the concentration range investigated (propofol 1.5-8 microg/mL and remifentanil 1-30 ng/mL) is a concave up hyperbola ((0.15. C(prop))(3.13). C(rem) = 1) with C(prop) = propofol plasma concentration [microg/mL] and C(rem) = remifentanil blood concentration [ng/mL]). Use of predicted (=TCI target) concentrations or the respective infusion rates did not alter the general shape of the interaction isobole.
Conclusions: The interaction between propofol and remifentanil for maintenance of a BIS value between 45 and 55 during surgery is synergistic. This finding applies regardless of whether measured concentrations (for propofol), predicted concentrations of the infusion device, or infusion rates are used as model input. Notably, the interaction isobole of the (clinically readily available) infusion rates provides a useful dosing recommendation for the coadministration of propofol and remifentanil during maintenance of anesthesia.
Similar articles
-
Bispectral index, predicted and measured drug levels of target-controlled infusions of remifentanil and propofol during laparoscopic cholecystectomy and emergence.Acta Anaesthesiol Scand. 2000 Oct;44(9):1138-44. doi: 10.1034/j.1399-6576.2000.440918.x. Acta Anaesthesiol Scand. 2000. PMID: 11028737 Clinical Trial.
-
Non-steady state analysis of the pharmacokinetic interaction between propofol and remifentanil.Anesthesiology. 2002 Dec;97(6):1350-62. doi: 10.1097/00000542-200212000-00005. Anesthesiology. 2002. PMID: 12459659 Clinical Trial.
-
Performance of propofol target-controlled infusion models in the obese: pharmacokinetic and pharmacodynamic analysis.Anesth Analg. 2014 Aug;119(2):302-310. doi: 10.1213/ANE.0000000000000317. Anesth Analg. 2014. PMID: 24977639
-
How obesity affects the disposition of intravenous anesthetics.Curr Opin Anaesthesiol. 2023 Aug 1;36(4):414-421. doi: 10.1097/ACO.0000000000001280. Epub 2023 Jun 8. Curr Opin Anaesthesiol. 2023. PMID: 37314170 Review.
-
[Modern concepts in pharmacokinetics of intravenous anesthetics].Anaesthesist. 2004 Jan;53(1):95-110. doi: 10.1007/s00101-003-0628-2. Anaesthesist. 2004. PMID: 14994741 Review. German.
Cited by
-
Spotlight on remifentanil for general anaesthesia.CNS Drugs. 2005;19(12):1069-74. doi: 10.2165/00023210-200519120-00010. CNS Drugs. 2005. PMID: 16332149 Review.
-
Remifentanil: a review of its use during the induction and maintenance of general anaesthesia.Drugs. 2005;65(13):1793-823. doi: 10.2165/00003495-200565130-00007. Drugs. 2005. PMID: 16114980 Review.
-
Clinically important drug interactions with intravenous anaesthetics in older patients.Drugs Aging. 2003;20(13):969-80. doi: 10.2165/00002512-200320130-00002. Drugs Aging. 2003. PMID: 14561101 Review.
-
Evaluation of propofol and remifentanil for intravenous sedation for reducing shoulder dislocations in the emergency department.Emerg Med J. 2006 Jan;23(1):57-8. doi: 10.1136/emj.2004.021410. Emerg Med J. 2006. PMID: 16373806 Free PMC article. Clinical Trial.
-
Interactions of propofol and remifentanil on bispectral index under 66% N(2)O: analysis by dose-effect curve, isobologram, and combination index.Korean J Anesthesiol. 2010 Dec;59(6):371-6. doi: 10.4097/kjae.2010.59.6.371. Epub 2010 Dec 31. Korean J Anesthesiol. 2010. PMID: 21253372 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous